SV Life Sciences Fund IV (GP), L.P.
CIK 1422340 · last filed 2019-02-21
SV Life Sciences Fund IV (GP), L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing shows the insider sold $17.6M of KALV on Feb 21, 2019. Across all open-market trades the lifetime net is −$267.7M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
3
-$267.68M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) Delisted | 10%+ Owner | 2,432,975 | $27.00 | $65.69M | -$17.61M | 1 | 2019-02-21 |
| IVERIC bio, Inc. (OPHT) Delisted | 10%+ Owner | 5,219,686 | — | — | -$250.07M | 1 | 2014-02-19 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-21 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Sell (S) | −856,792 | -$17.61M | EDGAR |
| 2014-02-19 | IVERIC bio, Inc. (OPHT) Delisted | Sell (S) | −8,445,456 | -$250.07M | EDGAR |
| 2010-05-05 | — | Sell (S) | −1,200,000 | -$12.30M |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.